IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 46 filers reported holding IRADIMED CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $279,000 | -33.6% | 7,500 | -63.0% | 0.00% | – |
| Q2 2018 | $420,000 | +42.4% | 20,250 | -1.2% | 0.00% | – |
| Q1 2018 | $295,000 | -5.1% | 20,500 | 0.0% | 0.00% | – |
| Q4 2017 | $311,000 | +57.9% | 20,500 | 0.0% | 0.00% | – |
| Q3 2017 | $197,000 | +23.9% | 20,500 | +10.8% | 0.00% | – |
| Q2 2017 | $159,000 | +18.7% | 18,500 | +23.3% | 0.00% | – |
| Q1 2017 | $134,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 715,877 | $32,100,000 | 4.18% |
| Soleus Capital Management, L.P. | 430,051 | $19,283,000 | 2.49% |
| RESOURCE CONSULTING GROUP INC | 128,000 | $5,740,000 | 1.99% |
| RK Capital | 213,200 | $9,560,000 | 1.88% |
| Capital Impact Advisors, LLC | 22,797 | $1,022,000 | 0.74% |
| G2 Investment Partners Management LLC | 61,326 | $2,750,000 | 0.65% |
| EAM Investors, LLC | 76,179 | $3,416,000 | 0.64% |
| Ranger Investment Management | 193,306 | $8,668,000 | 0.55% |
| EAM Global Investors LLC | 42,885 | $1,923,000 | 0.36% |
| Hillsdale Investment Management Inc. | 121,500 | $5,448,000 | 0.35% |